ISOLATION AND VALIDATION OF THE FIRST FUNCTIONAL HLA-A*01:01-RESTRICTED EBV-LMP2-SPECIFIC T-CELLS FOR TREATMENT OF EBV-ASSOCIATED TYPE II/III LYMPHOMAS: PS1314